gnipst bulletin 23.2

7/29/2019 Gnipst Bulletin 23.2

1/14

1118-1177-4796-9849-7562-5062mail

GNIPST BULLETIN 2013

8th March 2013 Volume No.: 23 Issue No.: 02

ContentsMessage from GNIPS

Letter to the EditorNews Update

Disease Outbreak Ne

Health Awareness

Forth Coming Events

Drugs Update

Campus News

Students Section

Editors Note

Archive

Vision

TO GROW AS A CENTRE OF EXCELLENCE IN THE FIELD O

PHARMACEUTICAL AND BIOLOGICAL SCIENCE

EDITOR: Debabrata Ghosh DastidarGURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE ANDTECHNOLOGY

GNIPST Photo Gallery

For your comments/contributionOR

For Back-Issues,

mailto:[email protected]

1
https://picasaweb.google.com/111714720327580099858/GNIPSTCricketTournament2013mailto:[email protected]:[email protected]:[email protected]://picasaweb.google.com/111714720327580099858/GNIPSTCricketTournament2013


2/14

08-03-2013

MESSAGE FROM GNIPSTAll the members of GNIPST are proud to publish the 23rd Volume

of GNIPST BULLETIN. This bulletin has successfully

completed its twenty months journey. We hope it has kept the

readers updated of recent activities in pharmaceutical & biological

sciences and also introduced them with the different activities of

our esteemed institution. We are thankful to all of you for your

great cooperation & support and are looking forward to the same in

future.

LETTER TO THE EDITOR.

NEWS UPDATE

Pour, Shake and Stir: How Gold Particles, DNAand Water Have the Potential to Shape the

Future of Medicine (28 FEBRUARY 2013)

A diagnostic "cocktail" containing a single drop of blood, a dribble

of water, and a dose of DNA powder with gold particles could

mean rapid diagnosis and treatment of the world's leading diseases

in the near future.Read moreUltrasound to Detect Lung Congestion in Dialysis

Patients May Help Save Lives (28 FEBRUARY 2013)

Click here to go at the top1
http://www.sciencedaily.com/releases/2013/02/130228171529.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171529.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171529.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171529.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29


3/14

08-03-2013

Lung ultrasound can detect asymptomatic lung congestion in

dialysis patients and can predict their risk of dying prematurely or

experiencing heart attacks or other cardiac events. Treating

asymptomatic lung congestion may help improve cardiovascular

health and prevent cardiovascular deaths in dialysis patients. Lung

congestion is highly prevalent and often asymptomatic among

patients with kidney failure.Read more

Machine Similar to Dialysis Removes Cholesterol

from Blood? (28 FEBRUARY 2013)

A treatment that's similar to kidney dialysis is removing

cholesterol from the blood of patients who cannot control

cholesterol through diet, exercise and medications.Read more

Excess Dietary Salt May Drive the Development

of Autoimmune Diseases(06 MARCH 2013)

Increased dietary salt intake can induce a group of aggressive

immune cells that are involved in triggering and sustaining

autoimmune diseases. In autoimmune diseases, the immune

system attacks healthy tissue instead of fighting pathogens. Inautoimmune diseases, the immune system attacks healthy tissue

instead of fighting pathogens.Read more

http://www.sciencedaily.com/releases/2013/02/130228171454.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171454.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171454.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171354.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171354.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171354.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/03/130306134358.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/03/130306134358.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/03/130306134358.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/03/130306134358.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171354.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/02/130228171454.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29


4/14

08-03-2013

Nanoparticles Loaded With Bee Venom Kill HIV

(07 MARCH 2013)

Nanoparticles carrying a toxin found in bee venom can destroy

human immunodeficiency virus (HIV) while leaving surrounding

cells unharmed, researchers have shown. The finding is an

important step toward developing a vaginal gel that may prevent

the spread of HIV, the virus that causes AIDS.Read more

HEALTH AWARENESS

MISUSE AND OVERUSE OF INJECTION WORLDWIDE

Injection is one of the most common health care procedures.

Each year at least 16 billion injections are administered in

developing and transitional countries. The vast majority, around

95%, are given in curative care. Immunization accounts for

around 3% of all injections, with the remainder for other

indications, including use of injections for transfusion of blood

and blood products and contraceptives.

In certain regions of the world, use of injections has completely

overtaken the real need, reaching proportions no longer based on

rational medical practice. In some situations, as many as nine out

of ten patients presenting to a primary healthcare provider

http://www.sciencedaily.com/releases/2013/03/130307160325.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/03/130307160325.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/03/130307160325.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/03/130307160325.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29


5/14

08-03-2013

receive an injection, over 70% of which are unnecessary or could

be given in an oral formulation.

Patients tend to prefer injections because they believe them to be

stronger and faster medications. They also believe that doctors

regard injections to be the best treatment. In turn, doctors over-

prescribe injections because they believe that this best satisfies

patients, even though patients are often open to alternatives. In

addition, prescription of an injection sometimes allows thecharging of a higher fee for service. Better communication

between patients and providers can clarify these types of

misunderstandings and help to reduce injection overuse.

UNSAFE INJECTION PRACTICES: A PLAGUE OF MANYHEALTH SYSTEM S

A safe injection does no harm. However, when safety control

practices are not respected, severe infections can result, putting

human lives at risk.

Reuse of syringes and needles in the absence of sterilization

exposes millions of people to infections. Assessments carried out

in numerous countries have revealed that syringes and needles

are often just rinsed in a pot of tepid water between injections.



6/14

08-03-2013

Worldwide, up to 40% of injections are given with syringes and

needles reused without sterilization and in some countries this

proportion is as high as 70%.

Other unsafe practices, such as poor collection and disposal of

dirty injection equipment, expose healthcare workers and the

community to the risk of needle stick injuries. In some countries

unsafe disposal can lead to re-sale of used equipment on the

black market. The proportion of non-industrialized countriesstill reporting that they use open burning of syringes (considered

unacceptable by WHO) was 50% in 2004.

BURDEN OF DISEASE ASSOCIATED WITH UNSAFE

INJECTION PRACTICES

The most recent study* indicates that each year unsafe injections

cause an estimated 1.3 million early deaths, a loss of 26 million

years of life, and an annual burden of USD 535 million in direct

medical costs.

Unsafe injection practices are a powerful engine to transmit

blood-borne pathogens, including hepatitis B virus (HBV),

hepatitis C virus (HCV) and human immunodeficiency virus

(HIV). Because infection with these viruses initially presents no



7/14

08-03-2013

symptoms, it is a silent epidemic. However, the consequences of

this are increasingly recognized.

Hepatitis B virus: HBV is highly infectious and causes the

highest number of infections: in developing and transitional

countries 21.7 million people become infected each year,

representing 33% of new HBV infections worldwide

Hepatitis C virus: Unsafe injections are the most common

cause of HCV infection in developing and transitional countries,causing two million new infections each year and accounting for

42% of cases.

Human immunodeficiency virus: Globally nearly 2% of all new

HIV infections are caused by unsafe injections. In South Asia up

to 9% of new cases may be caused in this way. Such proportions

can no longer be ignored.

HBV, HCV, and HIV cause chronic infections that lead to

disease, disability and death a number of years after the unsafe

injection. Those infected with hepatitis B virus in childhood will

typically present with chronic liver disease by the age of 30 years,

at the prime of their life. This has a dramatic effect on national

economies.



8/14

08-03-2013

*The cost of unsafe injections by M.A. Miller & E. Pisani:

Bulletin of the World Health Organization, Vol. 77, no 10, 808-

811.

SAFE AND APPROPRIATE USE OF INJECTIONS IS WITHIN

OUR GRASP

Unsafe injection practices are often viewed as a chronic problem

with no easy solution. However, safe and appropriate use of

injections can be achieved by adopting a three part strategy:

(1) Changing behaviour of health care workers and patients

Twenty years into the HIV pandemic, knowledge of HIV among

patients and health care workers in some countries has driven

consumer demand for safe injection equipment and irreversibly

improved injection practices. With growing knowledge of HCV

and HBV, similar patterns of consumer demand for safe

injections should emerge. HIV prevention programmes can be

expanded to include injection safety components.

(2) Ensuring availability of equipment and supplies

Simply increasing the availability of safe injection equipment can

stimulate demand and improve practices. Because the cost of safe



9/14

08-03-2013

disposable syringes is low (less than 5 US cents per unit) when

compared to the fee paid for receiving an injection (50 US cents

on average), patients are usually willing to pay a little extra for

safety once they personalize the risks.

(3) Managing waste safely and appropriately

As waste disposal is frequently not an integral part of health

planning, unsafe waste management is common. However, whenit is appropriately planned, significant results ensue. National

health care waste management strategies require a national

policy to manage health care waste, a comprehensive system for

implementation, improved awareness and training of health

workers at all levels, as well as the selection of appropriate

options for the local solutions.

DISEASE OUTBREAK NEWS

FORTHCOMING EVENTS

AICTE sponsored National Seminar on Recent Advances in the development

of Natural Antioxidant



10/14

08-03-2013

Date: 12 March 2013 13 March 2013, Venue: Department of Food

Technology, Guru Nanak Institute of Technology, 157/F, Nilgunj Road,

Panihati, Kolkata-700 114Details.

DRUGS UPDATES

FDA approves Stivarga for advanced

gastrointestinal stromal tumors(25FEBRUARY 2013

)The U.S. FDA expanded the approved use of Stivarga (regorafenib)

to treat patients with advanced gastrointestinal stromal tumors

(GIST) that cannot be surgically removed and no longer respond

to other FDA-approved treatments for this disease. Read more

FDA approves Osphena for postmenopausalwomen experiencing pain during sex

(26 FEBRUARY 2013)

The U.S. FDA approved Osphena (ospemifene) to treat women

experiencing moderate to severe dyspareunia (pain during sexual

intercourse), a symptom of vulvar and vaginal atrophy due to

menopause. Read more

http://www.gnit.ac.in/index.phphttp://www.gnit.ac.in/index.phphttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm340958.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm340958.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm341128.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm341128.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm341128.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm340958.htmhttp://www.gnit.ac.in/index.php


11/14

08-03-2013

CAMPUS NEWS

STUDENTS SECTION

WHO CAN ANSWER FIRST???() Which is the first patented organism in the

world?() August Dvorak and W. Dealy are associated

with invention of which computer device?Answer of Previous Issue Question:

A)Giraffe B)Butter

Send your thoughts/ Quiz/Puzzles/games/write-ups or any other contributions for Students Section& answers of this Section at [email protected]

EDITORS NOTE

I am very happy to publish the 22nd issue of 23rd Volume of GNIPST

BULLETIN. It is my great pleasure to introduce you to the newly

launched facebook account GNIPST bulletin. You are cordially

mailto:[email protected]:[email protected]:[email protected]


12/14

08-03-2013

invited to add this account to your friend list. The current issues will

also be directly available on facebook.

I would like to convey my thanks to all the GNIPST members and

the readers for their valuable comments, encouragement& supports.

Special thanks to Dr. Prerona Saha for her advice; Mr. Soumya

Bhattacharya, for his contribution instudents section.

It would be my great pleasure to receive the contributions,

suggestions & feedback from your desk for further upliftment of this

deliberation GNIPST BULLETIN.



13/14

08-03-2013

ARCHIVE

The general body meeting of APTI, Bengal Branch has been

conducted at GNIPST on 15th June, 2012. The programme started

with a nice presentation by Dr. Pulok Kr. Mukherjee, School of

Natural Products, JU on the skill to write a good manuscript for

publication in impact journals. It was followed by nearly two hour

long discussion among more than thirty participants on different

aspects of pharmacy education. Five nonmember participants

applied for membership on that very day.

GNIPST is now approved by AICTE and affiliated to WBUT forconducting the two years post graduate course (M.Pharm) in

PHARMACOLOGY. The approved number of seat is 18.The number of seats in B.Pharm. has been increased from 60 to

120.

2nd World Congress on Ga-68 (Generators and Novel Radiopharmaceuticals),

Molecular Imaging (PET/CT), Targeted Radionuclide Therapy, and

Dosimetry (SWC-2013) : On the Way to Personalized Medicine



14/14

08-03-2013

Dates 28 Feb 2013 02 Mar 2013

Location: Chandigarh, India.Details. AICTE has sanctioned a release of grant under Research

Promotion Scheme (RPS) during the financial year 2012-

13to GNIPST as per the details below:

a. Beneficiary Institution: Guru Nanak Institution of

Pharmaceutical Science & Technology.

b. Principal Investigator: Dr. LopamudraDutta.

c. Grant-in-aid sanctioned:Rs. 16,25000/- only

d. Approved duration: 3 years

e. Title of the project: Screening and identification of

potential medicinal plant of Purulia&Bankuradistricts of West

Bengal with respect to diseases such as diabetes, rheumatism,

Jaundice, hypertension and developing biotechnological tools forenhancing bioactive molecules in these plant.

http://www.2ndworldcongress-ga-68.de/http://www.2ndworldcongress-ga-68.de/http://www.2ndworldcongress-ga-68.de/http://www.2ndworldcongress-ga-68.de/

gnipst bulletin 23.2

Documents